文献速递儿童感染儿童呼吸

美国135794例儿科患者SARS-CoV-2检测评估

Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
PubMed 文献 · JAMA Pediatr · 2021-01-01

结果显示感染率为4%,临床多轻微,黑人、西班牙裔和亚裔检测率较低但阳性率较高,青少年和年轻成人及非呼吸系统慢性病与感染风险增加相关。

要点

  • 儿科SARS-CoV-2感染率低(4%),多表现为轻症。
  • 黑人、西班牙裔和亚裔检测率低但阳性率显著高于白人。
  • 非呼吸系统慢性病与阳性风险增加相关,呼吸系统疾病风险较低。

核心结论

  • 在美国儿科患者中,SARS-CoV-2感染率低且临床表现通常轻微。
  • 黑人、西班牙裔和亚裔种族/民族、青少年和年轻成人以及非呼吸系统慢性病与感染风险增加相关。
  • 川崎病诊断不能有效替代儿童多系统炎症综合征。

研究设计与样本

  • 回顾性队列研究,使用PEDSnet网络7个美国儿科健康系统的电子健康记录数据。

主要发现

  • 黑人、西班牙裔和亚裔相比白人检测率较低(OR分别为0.70、0.65、0.60),但阳性率较高(OR分别为2.66、3.75、2.04)。
  • 年龄较大(5-11岁OR 1.25;12-17岁OR 1.92;18-24岁OR 3.51)、公共支付方(OR 1.43)、门诊检测(OR 2.13)和急诊检测(OR 3.16)与感染风险增加相关。
  • 非恶性慢性病与检测可能性较低相关,呼吸系统疾病与阳性风险较低相关(SR 0.78)。
  • 多种诊断组与阳性风险较高相关:恶性疾病(SR 1.54)、心脏病(SR 1.18)、内分泌病(SR 1.52)、胃肠道疾病(SR 2.00)、遗传病(SR 1.19)、血液病(SR 1.26)、肌肉骨骼病(SR 1.18)、精神健康病(SR 1.20)、代谢病(SR 1.42)。

临床怎么用

  • 儿科医生应认识到儿童SARS-CoV-2感染多轻微,但需关注高风险群体如青少年、少数族裔及非呼吸系统慢性病患者。
  • 检测策略应考虑种族差异,确保公平检测机会。
  • 川崎病诊断不能作为儿童多系统炎症综合征的替代指标。

局限性

  • 回顾性研究设计可能引入偏倚。
  • 数据仅来自7个儿科健康系统,可能不能代表全美儿科人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: There is limited information on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and infection among pediatric patients across the United States. OBJECTIVE: To describe testing for SARS-CoV-2 and the epidemiology of infected patients. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted using electronic health record data from 135 794 patients younger than 25 years who were tested for SARS-CoV-2 from January 1 through September 8, 2020. Data were from PEDSnet, a network of 7 US pediatric health systems, comprising 6.5 million patients primarily from 11 states. Data analysis was performed from September 8 to 24, 2020. EXPOSURE: Testing for SARS-CoV-2. MAIN OUTCOMES AND MEASURES: SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) illness. RESULTS: A total of 135 794 pediatric patients (53% male; mean [SD] age, 8.8 [6.7] years; 3% Asian patients, 15% Black patients, 11% Hispanic patients, and 59% White patients; 290 per 10 000 population [range, 155-395 per 10 000 population across health systems]) were tested for SARS-CoV-2, and 5374 (4%) were infected with the virus (12 per 10 000 population [range, 7-16 per 10 000 population]). Compared with White patients, those of Black, Hispanic, and Asian race/ethnicity had lower rates of testing (Black: odds ratio [OR], 0.70 [95% CI, 0.68-0.72]; Hispanic: OR, 0.65 [95% CI, 0.63-0.67]; Asian: OR, 0.60 [95% CI, 0.57-0.63]); however, they were significantly more likely to have positive test results (Black: OR, 2.66 [95% CI, 2.43-2.90]; Hispanic: OR, 3.75 [95% CI, 3.39-4.15]; Asian: OR, 2.04 [95% CI, 1.69-2.48]). Older age (5-11 years: OR, 1.25 [95% CI, 1.13-1.38]; 12-17 years: OR, 1.92 [95% CI, 1.73-2.12]; 18-24 years: OR, 3.51 [95% CI, 3.11-3.97]), public payer (OR, 1.43 [95% CI, 1.31-1.57]), outpatient testing (OR, 2.13 [1.86-2.44]), and emergency department testing (OR, 3.16 [95% CI, 2.72-3.67]) were also associated with increased risk of infection. In univariate analyses, nonmalignant chronic disease was associated with lower likelihood of testing, and preexisting respiratory conditions were associated with lower risk of positive test results (standardized ratio [SR], 0.78 [95% CI, 0.73-0.84]). However, several other diagnosis groups were associated with a higher risk of positive test results: malignant disorders (SR, 1.54 [95% CI, 1.19-1.93]), cardiac disorders (SR, 1.18 [95% CI, 1.05-1.32]), endocrinologic disorders (SR, 1.52 [95% CI, 1.31-1.75]), gastrointestinal disorders (SR, 2.00 [95% CI, 1.04-1.38]), genetic disorders (SR, 1.19 [95% CI, 1.00-1.40]), hematologic disorders (SR, 1.26 [95% CI, 1.06-1.47]), musculoskeletal disorders (SR, 1.18 [95% CI, 1.07-1.30]), mental health disorders (SR, 1.20 [95% CI, 1.10-1.30]), and metabolic disorders (SR, 1.42 [95% CI, 1.24-1.61]). Among the 5374 patients with positive test results, 359 (7%) were hospitalized for respiratory, hypotensive, or COVID-19-specific illness. Of these, 99 (28%) required intensive care unit services, and 33 (9%) required mechanical ventilation. The case fatality rate was 0.2% (8 of 5374). The number of patients with a diagnosis of Kawasaki disease in early 2020 was 40% lower (259 vs 433 and 430) than in 2018 or 2019. CONCLUSIONS AND RELEVANCE: In this large cohort study of US pediatric patients, SARS-CoV-2 infection rates were low, and clinical manifestations were typically mild. Black, Hispanic, and Asian race/ethnicity; adolescence and young adulthood; and nonrespiratory chronic medical conditions were associated with identified infection. Kawasaki disease diagnosis is not an effective proxy for multisystem inflammatory syndrome of childhood.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Bailey LC, Razzaghi H, Burrows EK, et al. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr. 2021. PMID: 33226415. doi:10.1001/jamapediatrics.2020.5052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。